Chloroquine-resistant Plasmodium falciparum: protective and hemolytic effects of 4,4'-diaminodiphenylsulfone (DDS) administered daily together with weekly chloroquine and primaquine.
D000328:Adult; D001741:Black or African American; D002738:Chloroquine / Q000008:administration & dosage*; D003622:Dapsone / Q000008:administration & dosage*; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D008288:Malaria / Q000517:prevention & control*; D008297:Male; D010963:Plasmodium falciparum / Q000187:drug effects; D011319:Primaquine / Q000008:administration & dosage*; D044465:White People
D002738:Chloroquine; D003622:Dapsone; D011319:Primaquine